EGFR and glioblastoma: Treatment of both EJ28Luc bladder cancer and LN18 glioblastoma cells with 213Bi-anti-EGFR-MAb (1.48 MBq/ml) effectively eradicated tumor cells, as monitored via microscopical observation.